8598953

Source:http://linkedlifedata.com/resource/pubmed/id/8598953

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005974, umls-concept:C0083220, umls-concept:C0087111, umls-concept:C0181904, umls-concept:C0285526, umls-concept:C0596972, umls-concept:C0728873, umls-concept:C1521743, umls-concept:C1524119, umls-concept:C1704646
pubmed:issue	3
pubmed:dateCreated	1996-4-23
pubmed:abstractText	To assess the utility of urinary cross-linked N-telopeptides in monitoring bone resorption and predicting bone loss during GnRH agonist administration.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401101
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Collagen, http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Goserelin, http://linkedlifedata.com/resource/pubmed/chemical/Hormones, http://linkedlifedata.com/resource/pubmed/chemical/Leuprolide, http://linkedlifedata.com/resource/pubmed/chemical/Nafarelin, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric...
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0029-7844
pubmed:author	pubmed-author:CainD FDF, pubmed-author:ChesnutC HCH3rd, pubmed-author:DmowskiW PWP, pubmed-author:MarshallL ALA
pubmed:issnType	Print
pubmed:volume	87
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	350-4
pubmed:dateRevised	2009-10-26
pubmed:meshHeading	pubmed-meshheading:8598953-Adult, pubmed-meshheading:8598953-Antineoplastic Agents, Hormonal, pubmed-meshheading:8598953-Bone Density, pubmed-meshheading:8598953-Bone Resorption, pubmed-meshheading:8598953-Collagen, pubmed-meshheading:8598953-Collagen Type I, pubmed-meshheading:8598953-Endometriosis, pubmed-meshheading:8598953-Estradiol, pubmed-meshheading:8598953-Female, pubmed-meshheading:8598953-Follicle Stimulating Hormone, pubmed-meshheading:8598953-Genital Neoplasms, Female, pubmed-meshheading:8598953-Gonadotropin-Releasing Hormone, pubmed-meshheading:8598953-Goserelin, pubmed-meshheading:8598953-Hormones, pubmed-meshheading:8598953-Humans, pubmed-meshheading:8598953-Leiomyoma, pubmed-meshheading:8598953-Leuprolide, pubmed-meshheading:8598953-Middle Aged, pubmed-meshheading:8598953-Nafarelin, pubmed-meshheading:8598953-Peptides, pubmed-meshheading:8598953-Prospective Studies, pubmed-meshheading:8598953-Uterine Neoplasms
pubmed:year	1996
pubmed:articleTitle	Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy.
pubmed:affiliation	Section of Reproductive Endocrinology, Virginia Mason Medical Center, Seattle, WA, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study